Indivior PLC at Morgan Stanley Global Healthcare Conference Transcript
Good morning, everyone. Thank you for joining this session as a Morgan Stanley Global Healthcare Conference. My name is Thibault Boutherin. I am part of the pharma equity research team based in London. Before we start, I just need to read some -- to refer to some important disclosures. Please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley (inaudible)
So for this session, I am delighted to have with me Mark Crossley, CEO of Indivior. And thank you very much for joining us today. So we will sharply start with the Q&A. But before that, Mark, do you want to maybe start with some [commentary] comments.
Certainly. And I'll layer on some disclosures with forward-looking statements that are available on indivior.com, if
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |